Home - geneType

Genomics is more than family history. 

Genetic Technologies is a World Leader in Genetic Risk Assessment. Our brand geneType offers integrated risk testing for a range of serious conditions.

By knowing your risk, you and your healthcare professional can put together a personalised preventive health plan, and may help save your life.

Comprehensive Risk Prediction

Find our what your DNA says about you, your family and your lifestyle. Designed for those who may have a family history of cancer, cardiovascular and metabolic disease and want to know their individual risk.

Risk Stratification Panel for Men

Risk Stratification Panel for Women

Multi-Risk Test

Develop your own personalized preventative pathway with a healthcare professional. Designed for those who know their family history and want to further understand their disease risk.

GeneType Multi-Risk Test for Men

GeneType Multi-Risk Test for Women

Protect your future with geneType risk assessment.

  • Simple saliva collection
  • Clinically actionable results
  • Complementary access to a genetic counsellor for all patients and healthcare professionals
  • Only NATA accredited & CLIA certified lab in Australia providing polygenic risk score testing
  • Your privacy is assured with data used only for a single purpose

Speak to your medical practitioner about whether this test is right for you.

A leader in personalised predictive genetics

GeneType Integrated Risk, Polygenic Risk (PRS) and Clinical Risk (CRS)

Inherited Monogenic Disease (Germline)

Carrier Testing

Non-invasive Prenatal Testing

Pharmacogenetic Testing

DNA Testing (Ancestry, Paternity)

Intolerance Test

PetgenTM Animal Test

DNA Storage

Know your breast cancer risk.

For women who want to live life on their terms.

The simple act of knowing whether you are at increased risk of developing breast cancer may be enough to change the course of your life.

GeneType for Breast Cancer looks beyond family history, it combines familial, genetic and clinical risk factors to provide you with a more comprehensive risk profile.¹

 With this information, you and your healthcare professional can then develop a personalised preventive health plan – that may change the course of your life.

Take the first step towards personalised, preventative healthcare

Knowing your personalised risk enables you to develop a health plan with your healthcare professional to reduce your risk of serious disease. Select from the tests below to take the first step to managing your risk.

Breast Cancer

Find out if you are at increased risk of developing breast cancer

Colorectal Cancer

Find out if you are at increased risk of developing bowel (colorectal) cancer

Ovarian Cancer

Find out if you are at increased risk of developing a ovarian cancer

Prostate Cancer

Find out if you are at increased risk of developing a prostate cancer

Coronary Artery Disease

Find out if you are at increased risk of developing coronary artery disease

Type 2 Diabetes

Find out if you are at increased risk of developing type 2 diabetes

Multi-Risk Test

Find out if you are at increased risk of developing a wide range of cancers as well as heart disease and type 2 diabetes

Mental Health

Find out which antidepressant and dose could maximise your response and minimise side effects

Other Conditions

Find out if you are at increased risk of developing conditions such as glaucoma, melanoma or atrial fibrillation

Quality matters
and geneType delivers.

Our expert scientific team has dedicated the last 20 years to translating research into validated clinical tests with actionable outcomes for patients.

Our extensive range of patents, peer-reviewed publications and validated tests reflects this commitment to making personalised, predictive healthcare a reality.

Innovation

GeneType gives you the tools you need to provide personalised, preventative healthcare.

Genetype tests integrates clinical, familial and genetic risk factors to provide a more comprehensive risk profile.

For example, geneType for Breast Cancer supports identification of four times as many women who are at high risk for breast cancer compared with traditional prediction models.²

This information will then allow you and your healthcare professional to develop personalised, preventive health plans based on screening and risk factor management.

Keep up-to-date with our latest advances 

Sign up to our newsletter to stay informed about our latest advances and how these could support your practice. 

Accredited For Compliance With NPAAC Standards And ISO 15189

CLIA Number 99D2023356